Steven Cohen acquired 3.52 Million Caribou Biosciences shares worth $13.1 Million. That's 0.04% of their equity portfolio (464th largest holding). The investor owns 3.90% of the outstanding Caribou Biosciences stock. The first Caribou Biosciences trade was made in Q3 2021. Since then Steven Cohen bought shares three more times and sold shares on one occasions. The investor's estimated purchase price is $22.6 Million, resulting in a loss of 42%.